User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin : A Belgian Multicentre Prospective Phase II Clinical Study.

  1. Verwaal Vic J., van Ruth Serge, Witkamp Arjen, Boot Henk, van Slooten Gooike, Zoetmulder Frans A. N., Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin, 10.1007/s10434-004-1167-z
  2. Setti Carraro Paolo G., Segala Marco, Cesana Bruno M., Tiberio Giorgio, Obstructing colonic cancer : Failure and survival patterns over a ten-year follow-up after one-stage curative surgery, 10.1007/bf02234300
  3. Jayne D. G., Fook S., Loi C., Seow-Choen F., Peritoneal carcinomatosis from colorectal cancer, 10.1046/j.1365-2168.2002.02274.x
  4. Russell Anthony H., Pelton James, Reheis Christine E., Wisbeck William M., Tong Daphne Y., Dawson Lynne E., Adenocarcinoma of the colon: An autopsy study with implications for new therapeutic strategies, 10.1002/1097-0142(19850915)56:6<1446::aid-cncr2820560636>3.0.co;2-5
  5. Koppe Manuel J., Boerman Otto C., Oyen Wim J. G., Bleichrodt Robert P., Peritoneal Carcinomatosis of Colorectal Origin : Incidence and Current Treatment Strategies, 10.1097/01.sla.0000197702.46394.16
  6. Sadeghi Babak, Arvieux Catherine, Glehen Olivier, Beaujard Annie C., Rivoire Michel, Baulieux Jacques, Fontaumard Eric, Brachet Alain, Caillot Jean L., Faure Jean L., Porcheron Jack, Peix Jean L., Fran�ois Yves, Vignal Jacques, Gilly Fran�ois N., Peritoneal carcinomatosis from non-gynecologic malignancies : Results of the EVOCAPE 1 multicentric prospective study, 10.1002/(sici)1097-0142(20000115)88:2<358::aid-cncr16>3.0.co;2-o
  7. Shen Perry, Factors Predicting Survival After Intraperitoneal Hyperthermic Chemotherapy With Mitomycin C After Cytoreductive Surgery for Patients With Peritoneal Carcinomatosis, 10.1001/archsurg.138.1.26
  8. Sugarbaker P. H., Management of peritoneal-surface malignancy: the surgeon's role, 10.1007/s004230050246
  9. Ragnhammar Peter, Hafström Larsolof, Nygren Peter, Glimelius Bengt, A Systematic Overview of Chemotherapy Effects in Colorectal Cancer, 10.1080/02841860151116367
  10. Pestieau Sophie R., Belliveau Jim F., Griffin Hank, Stuart O. Anthony, Sugarbaker Paul H., Pharmacokinetics of intraperitoneal oxaliplatin: Experimental studies, 10.1002/1096-9098(200102)76:2<106::aid-jso1020>3.0.co;2-e
  11. Mahteme H., Wallin I., Glimelius B., Påhlman L., Ehrsson H., Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion, 10.1007/s00228-008-0511-9
  12. Elias D., Bonnay M., Puizillou J. M., Antoun S., Demirdjian S., El Otmany A., Pignon J. P., Drouard-Troalen L., Ouellet J. F., Ducreux M., Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution, 10.1093/annonc/mdf019
  13. Jacquet Pierre, Sugarbaker Paul H., Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, Cancer Treatment and Research (1996) ISBN:9781461285311 p.359-374, 10.1007/978-1-4613-1247-5_23
  14. Sugarbaker Paul H., Peritonectomy procedures, 10.1016/s1055-3207(03)00048-6
  15. Harrell Frank E., Regression Modeling Strategies, ISBN:9781441929181, 10.1007/978-1-4757-3462-1
  16. Heinze Georg, Gnant Michael, Schemper Michael, Exact Log-Rank Tests for Unequal Follow-Up, 10.1111/j.0006-341x.2003.00132.x
  17. Elias D., Blot F., El Otmany A., Antoun S., Lasser P., Boige V., Rougier P., Ducreux M., Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy, 10.1002/1097-0142(20010701)92:1<71::aid-cncr1293>3.0.co;2-9
  18. van Leeuwen B. L., Graf W., Pahlman L., Mahteme H., Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis, 10.1245/s10434-007-9700-5
  19. Elias Dominique, Glehen Olivier, Pocard Marc, Quenet François, Goéré Diane, Arvieux Catherine, Rat Patrick, Gilly François, A Comparative Study of Complete Cytoreductive Surgery Plus Intraperitoneal Chemotherapy to Treat Peritoneal Dissemination From Colon, Rectum, Small Bowel, and Nonpseudomyxoma Appendix : , 10.1097/sla.0b013e3181d9765d
  20. Elias Dominique, Gilly François, Boutitie Florent, Quenet François, Bereder Jean-Marc, Mansvelt Baudouin, Lorimier Gérard, Dubè Pierre, Glehen Olivier, Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study, 10.1200/jco.2009.23.9285
  21. Glehen O., Kwiatkowski F., Sugarbaker P.H., Elias D., Levine E.A., De Simone M., Barone R., Yonemura Y., Cavaliere F., Quenet F., Gutman M., Tentes A.A.K., Lorimier G., Bernard J.L., Bereder J.M., Porcheron J., Gomez-Portilla A., Shen P., Deraco M., Rat P., Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study, 10.1200/jco.2004.10.012
  22. Elias Dominique, Lefevre Jérémie H., Chevalier Julie, Brouquet Antoine, Marchal Frédéric, Classe Jean-Marc, Ferron Gwenaël, Guilloit Jean-Marc, Meeus Pierre, Goéré Diane, Bonastre Julia, Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin, 10.1200/jco.2008.19.7160
  23. Elias Dominique M., Pocard Marc, Treatment and prevention of peritoneal carcinomatosis from colorectal cancer, 10.1016/s1055-3207(03)00049-8
  24. Cao Christopher, Yan Tristan D., Black Deborah, Morris David L., A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin, 10.1245/s10434-009-0487-4
  25. Elias D, Pocard M, Goere D, et al. HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. Cancer Treat Res. 2007;134:303–18.
  26. Andres Axel, Majno Pietro E., Morel Philippe, Rubbia-Brandt Laura, Giostra Emiliano, Gervaz Pascal, Terraz Sylvain, Allal Abdelkarim S., Roth Arnaud D., Mentha Gilles, Improved Long-Term Outcome of Surgery for Advanced Colorectal Liver Metastases: Reasons and Implications for Management on the Basis of a Severity Score, 10.1245/s10434-007-9607-1
  27. Arru Marcella, Aldrighetti Luca, Castoldi Renato, Di Palo Saverio, Orsenigo Elena, Stella Marco, Pulitanò Carlo, Gavazzi Francesca, Ferla Gianfranco, Di Carlo Valerio, Staudacher Carlo, Analysis of Prognostic Factors Influencing Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer, 10.1007/s00268-007-9285-y
  28. Choti Michael A., Sitzmann James V., Tiburi Marcelo F., Sumetchotimetha Wuthi, Rangsin Ram, Schulick Richard D., Lillemoe Keith D., Yeo Charles J., Cameron John L., Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases : , 10.1097/00000658-200206000-00002
  29. Zakaria Shaheen, Donohue John H., Que Florencia G., Farnell Michael B., Schleck Cathy D., Ilstrup Duane M., Nagorney David M., Hepatic Resection for Colorectal Metastases : Value for Risk Scoring Systems?, 10.1097/sla.0b013e3180603039
  30. House Michael G., Ito Hiromichi, Gönen Mithat, Fong Yuman, Allen Peter J., DeMatteo Ronald P., Brennan Murray F., Blumgart Leslie H., Jarnagin William R., D'Angelica Michael I., Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution, 10.1016/j.jamcollsurg.2009.12.040
  31. Maggiori L., Elias D., Curative treatment of colorectal peritoneal carcinomatosis: Current status and future trends, 10.1016/j.ejso.2010.05.007
  32. Kusamura Shigeki, Dominique Elias, Baratti Dario, Younan Rami, Deraco Marcello, Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy, 10.1002/jso.21051
  33. Verwaal Vic J., van Ruth Serge, de Bree Eelco, van Slooten Gooike W., van Tinteren Harm, Boot Henk, Zoetmulder Frans A.N., Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer, 10.1200/jco.2003.04.187
  34. Verwaal Vic J., Bruin Sjoerd, Boot Henk, van Slooten Gooike, van Tinteren Harm, 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer, 10.1245/s10434-008-9966-2
  35. Franko Jan, Ibrahim Zuhaib, Gusani Niraj J., Holtzman Matthew P., Bartlett David L., Zeh Herbert J., Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis, 10.1002/cncr.25116
  36. Hompes Daphne, Boot Henk, van Tinteren Harm, Verwaal Victor, Unresectable peritoneal carcinomatosis from colorectal cancer: A single center experience, 10.1002/jso.21937
  37. van Ruth Serge, Math??t Ron A A, Sparidans Rolf W, Beijnen Jos H, Verwaal Vic J, Zoetmulder Frans A N, Population Pharmacokinetics and Pharmacodynamics of Mitomycin During Intraoperative Hyperthermic Intraperitoneal Chemotherapy : , 10.2165/00003088-200443020-00005
  38. van Ruth S., Verwaal V.J., Zoetmulder F.A.N., Pharmacokinetics of intraperitoneal mitomycin C, 10.1016/s1055-3207(03)00031-0
  39. Lambert Laura A., Armstrong Terri S., Lee J. Jack, Liu Suyu, Katz Matthew H. G., Eng Cathy, Wolff Robert A., Tortorice Melissa L., Tansey Pier, Gonzalez-Moreno Santiago, Lambert Donald H., Mansfield Paul F., Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C, 10.1245/s10434-009-0523-4
  40. Verwaal Vic J., Tinteren Harm van, Ruth Serge V., Zoetmulder Frans A.N., Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy, 10.1002/jso.20013
  41. Graham M, Lockwood G, Greenslade D. Clinical pharmacokinetics of oxaliplatin: a critical review. Clin Cancer Res. 2000;6:1205–18.
  42. Soulié P, Raymond E, Brienza S, et al. Oxaliplatin: the first DACH platinum in clinical practice. Bull Cancer. 1997;84:665–73.
  43. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., Boni C., Cortes-Funes H., Cervantes A., Freyer G., Papamichael D., Le Bail N., Louvet C., Hendler D., de Braud F., Wilson C., Morvan F., Bonetti A., Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer, 10.1200/jco.2000.18.16.2938
  44. Makatsoris Thomas, Kalofonos Haralabos P., Aravantinos Gerasimos, Papadimitriou Christos, Kastritis Efstathios, Rigatos Sotirios K., Xiros Nikolaos, Petsas Theodore, Economopoulos Theofanis, Sakadamis Athanassios K., Fountzilas George, A Phase II Study of Capecitabine Plus Oxaliplatin (XELOX): A New First-Line Option in Metastatic Colorectal Cancer, 10.1385/ijgc:35:2:103
  45. Scheithauer Werner, Kornek Gabriela V., Raderer Markus, Schüll Birgit, Schmid Katharina, Kovats Erwin, Schneeweiss Bruno, Lang Fritz, Lenauer Alfred, Depisch Dieter, Randomized Multicenter Phase II Trial of Two Different Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer, 10.1200/jco.2003.09.016
Bibliographic reference Hompes, Daphne ; D'Hoore, André ; Van Cutsem, Eric ; Fieuws, Steffen ; Ceelen, Wim ; et. al. The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin. In: Annals of Surgical Oncology, Vol. 19, no. 7, p. 2186-2194 (2012)
Permanent URL http://hdl.handle.net/2078.1/112787